US Stock MarketDetailed Quotes

KRBP Kiromic BioPharma

Watchlist

3.010
-0.170-5.35%

15min DelayClose Jun 4 16:00 ET

4.64MMarket Cap-405P/E (TTM)

Kiromic BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

7.03%5.11M

-35.92%19.94M

-23.17%5.32M

-33.88%5.55M

-49.10%4.29M

-35.14%4.78M

22.95%31.11M

-32.38%6.92M

36.69%8.4M

69.59%8.43M

Selling and administrative expenses

-22.61%2.09M

-40.01%10.31M

-32.85%2.41M

-37.67%2.87M

-48.90%2.33M

-39.13%2.7M

23.36%17.19M

-47.93%3.59M

73.66%4.61M

96.69%4.55M

-General and administrative expense

-22.61%2.09M

-40.01%10.31M

-32.85%2.41M

-37.67%2.87M

-48.90%2.33M

-39.13%2.7M

23.36%17.19M

-47.93%3.59M

73.66%4.61M

96.69%4.55M

Research and development costs

45.64%3.02M

-30.86%9.62M

-12.72%2.91M

-29.25%2.68M

-49.32%1.97M

-29.08%2.08M

22.45%13.92M

-0.23%3.33M

8.53%3.78M

46.00%3.88M

Operating profit

-7.03%-5.11M

35.92%-19.94M

23.17%-5.32M

33.88%-5.55M

49.10%-4.29M

35.14%-4.78M

-22.95%-31.11M

32.38%-6.92M

-36.69%-8.4M

-69.59%-8.43M

Net non-operating interest income expense

-104.78%-1.07M

-1,012.43%-1.85M

-296.55%-632.9K

-30,885.71%-433.8K

-25,896.30%-701.9K

-18,578.57%-523K

-1,264.75%-166.5K

-2,605.08%-159.6K

-180.00%-1.4K

-28.57%-2.7K

Non-operating interest expense

141.22%1.07M

1,012.43%1.85M

296.55%632.9K

30,885.71%433.8K

12,322.22%335.4K

15,757.14%444K

1,264.75%166.5K

2,605.08%159.6K

180.00%1.4K

28.57%2.7K

Total other finance cost

----

--366.5K

--79K

----

Other net income (expense)

36K

124.41%842.2K

9,739.84%1.26M

151.75%1.79M

-1.77M

-1,174.08%-3.45M

103.24%12.8K

-19,338.89%-3.46M

Special income (charges)

----

50.04%-1.73M

--0

---1.77M

----

-968.17%-3.46M

--0

---3.46M

--0

-Less:Other special charges

----

-50.04%1.73M

--0

----

--1.77M

----

3,373.16%3.46M

--0

--3.46M

----

Other non- operating income (expenses)

--36K

19,995.31%2.57M

--1.26M

--1.79M

----

-76.03%12.8K

----

Income before tax

-16.00%-6.15M

39.68%-20.95M

33.63%-4.69M

64.64%-4.19M

19.81%-6.76M

28.07%-5.3M

-35.73%-34.73M

33.54%-7.07M

-93.64%-11.86M

-69.57%-8.44M

Income tax

Net income

-16.00%-6.15M

39.68%-20.95M

33.63%-4.69M

64.64%-4.19M

19.81%-6.76M

28.07%-5.3M

-35.73%-34.73M

33.54%-7.07M

-93.64%-11.86M

-69.57%-8.44M

Net income continuous Operations

-16.00%-6.15M

39.68%-20.95M

33.63%-4.69M

64.64%-4.19M

19.81%-6.76M

28.07%-5.3M

-35.73%-34.73M

33.54%-7.07M

-93.64%-11.86M

-69.57%-8.44M

Minority interest income

Net income attributable to the parent company

-16.00%-6.15M

39.68%-20.95M

33.63%-4.69M

64.64%-4.19M

19.81%-6.76M

28.07%-5.3M

-35.73%-34.73M

33.54%-7.07M

-93.64%-11.86M

-69.57%-8.44M

Preferred stock dividends

Other preferred stock dividends

1,047.06%975K

639.62%2.55M

1,015.19%969.1K

930.03%895.1K

599.65%601K

-0.12%85K

55.32%344.8K

0.00%86.9K

1.64%86.9K

244.98%85.9K

Net income attributable to common stockholders

-32.27%-7.12M

33.00%-23.5M

20.89%-5.66M

57.41%-5.09M

13.56%-7.37M

27.75%-5.39M

-35.90%-35.08M

33.27%-7.15M

-92.38%-11.95M

-70.45%-8.52M

Basic earnings per share

83.79%-1

80.46%-12.59

62.49%-4.16

93.28%-1.52

80.18%-3.22

57.12%-6.17

5.00%-64.42

51.39%-11.09

-88.58%-22.63

20.34%-16.25

Diluted earnings per share

83.79%-1

80.46%-12.59

62.49%-4.16

93.28%-1.52

80.18%-3.22

57.12%-6.17

5.00%-64.42

51.39%-11.09

-88.58%-22.63

20.34%-16.25

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	7.03%5.11M	-35.92%19.94M	-23.17%5.32M	-33.88%5.55M	-49.10%4.29M	-35.14%4.78M	22.95%31.11M	-32.38%6.92M	36.69%8.4M	69.59%8.43M
Selling and administrative expenses	-22.61%2.09M	-40.01%10.31M	-32.85%2.41M	-37.67%2.87M	-48.90%2.33M	-39.13%2.7M	23.36%17.19M	-47.93%3.59M	73.66%4.61M	96.69%4.55M
-General and administrative expense	-22.61%2.09M	-40.01%10.31M	-32.85%2.41M	-37.67%2.87M	-48.90%2.33M	-39.13%2.7M	23.36%17.19M	-47.93%3.59M	73.66%4.61M	96.69%4.55M
Research and development costs	45.64%3.02M	-30.86%9.62M	-12.72%2.91M	-29.25%2.68M	-49.32%1.97M	-29.08%2.08M	22.45%13.92M	-0.23%3.33M	8.53%3.78M	46.00%3.88M
Operating profit	-7.03%-5.11M	35.92%-19.94M	23.17%-5.32M	33.88%-5.55M	49.10%-4.29M	35.14%-4.78M	-22.95%-31.11M	32.38%-6.92M	-36.69%-8.4M	-69.59%-8.43M
Net non-operating interest income expense	-104.78%-1.07M	-1,012.43%-1.85M	-296.55%-632.9K	-30,885.71%-433.8K	-25,896.30%-701.9K	-18,578.57%-523K	-1,264.75%-166.5K	-2,605.08%-159.6K	-180.00%-1.4K	-28.57%-2.7K
Non-operating interest expense	141.22%1.07M	1,012.43%1.85M	296.55%632.9K	30,885.71%433.8K	12,322.22%335.4K	15,757.14%444K	1,264.75%166.5K	2,605.08%159.6K	180.00%1.4K	28.57%2.7K
Total other finance cost	----	----	----	----	--366.5K	--79K	----	----	----	----
Other net income (expense)	36K	124.41%842.2K	9,739.84%1.26M	151.75%1.79M	-1.77M		-1,174.08%-3.45M	103.24%12.8K	-19,338.89%-3.46M
Special income (charges)	----	50.04%-1.73M	--0	--0	---1.77M	----	-968.17%-3.46M	--0	---3.46M	--0
-Less:Other special charges	----	-50.04%1.73M	--0	----	--1.77M	----	3,373.16%3.46M	--0	--3.46M	----
Other non- operating income (expenses)	--36K	19,995.31%2.57M	--1.26M	--1.79M	----	----	-76.03%12.8K	----	----	----
Income before tax	-16.00%-6.15M	39.68%-20.95M	33.63%-4.69M	64.64%-4.19M	19.81%-6.76M	28.07%-5.3M	-35.73%-34.73M	33.54%-7.07M	-93.64%-11.86M	-69.57%-8.44M
Income tax
Net income	-16.00%-6.15M	39.68%-20.95M	33.63%-4.69M	64.64%-4.19M	19.81%-6.76M	28.07%-5.3M	-35.73%-34.73M	33.54%-7.07M	-93.64%-11.86M	-69.57%-8.44M
Net income continuous Operations	-16.00%-6.15M	39.68%-20.95M	33.63%-4.69M	64.64%-4.19M	19.81%-6.76M	28.07%-5.3M	-35.73%-34.73M	33.54%-7.07M	-93.64%-11.86M	-69.57%-8.44M
Minority interest income
Net income attributable to the parent company	-16.00%-6.15M	39.68%-20.95M	33.63%-4.69M	64.64%-4.19M	19.81%-6.76M	28.07%-5.3M	-35.73%-34.73M	33.54%-7.07M	-93.64%-11.86M	-69.57%-8.44M
Preferred stock dividends
Other preferred stock dividends	1,047.06%975K	639.62%2.55M	1,015.19%969.1K	930.03%895.1K	599.65%601K	-0.12%85K	55.32%344.8K	0.00%86.9K	1.64%86.9K	244.98%85.9K
Net income attributable to common stockholders	-32.27%-7.12M	33.00%-23.5M	20.89%-5.66M	57.41%-5.09M	13.56%-7.37M	27.75%-5.39M	-35.90%-35.08M	33.27%-7.15M	-92.38%-11.95M	-70.45%-8.52M
Basic earnings per share	83.79%-1	80.46%-12.59	62.49%-4.16	93.28%-1.52	80.18%-3.22	57.12%-6.17	5.00%-64.42	51.39%-11.09	-88.58%-22.63	20.34%-16.25
Diluted earnings per share	83.79%-1	80.46%-12.59	62.49%-4.16	93.28%-1.52	80.18%-3.22	57.12%-6.17	5.00%-64.42	51.39%-11.09	-88.58%-22.63	20.34%-16.25
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall